Diabetes and metabolic dysfunction in COPD

World Health Organisation Donner, 1997, CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus, J Clin Endocrinol Metab, 82, 143, 10.1210/jc.82.1.143 Nathan, 2007, Impaired fasting glucose and impaired glucose tolerance: implications for care, Diabetes Care, 30, 753, 10.2337/dc07-9920 Rolih, 1995, The endocrine response to critical illness, Med Clin North Am, 79, 211, 10.1016/S0025-7125(16)30093-1 McGuinness, 2005, Defective glucose homeostasis during infection, Annu Rev Nutr, 25, 9, 10.1146/annurev.nutr.24.012003.132159 Baker, 2006, Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease, Thorax, 61, 284, 10.1136/thx.2005.051029 Chatila, 2008, Comorbidities in chronic obstructive pulmonary disease, Proc Am Thorac Soc, 5, 549, 10.1513/pats.200709-148ET Mannino, 2008, Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD, Eur Respir J, 32, 962, 10.1183/09031936.00012408 Rana, 2004, Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women, Diabetes Care, 27, 2478, 10.2337/diacare.27.10.2478 Chung, 2001, Cytokines in chronic obstructive pulmonary disease, Eur Respir J Suppl, 34, 50s, 10.1183/09031936.01.00229701 Eid, 2001, Inflammatory response and body composition in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 164, 1414, 10.1164/ajrccm.164.8.2008109 Hu, 2004, Inflammatory markers and risk of developing type 2 diabetes in women, Diabetes, 53, 693, 10.2337/diabetes.53.3.693 Bolton, 2007, Insulin resistance and inflammation – a further systemic complication of COPD, COPD, 4, 121, 10.1080/15412550701341053 Grimble, 2002, Inflammatory status and insulin resistance, Curr Opin Clin Nutr Metab Care, 5, 551, 10.1097/00075197-200209000-00015 Liu, 1998, Tumour necrosis factor-alpha acutely inhibits insulin signaling in human adipocycyes – implication of the P80 tumor necrosis factor receptor, Diabetes, 47, 515, 10.2337/diabetes.47.4.515 Oltmanns, 2004, Hypoxia causes glucose intolerance in humans, Am J Respir Crit Care Med, 169, 1231, 10.1164/rccm.200308-1200OC Hjalmarsen, 1996, Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease, Diabetes Metab, 22, 37 Jakobsson, 2006, Oxygen supplementation increases glucose tolerance during euglycaemic hyperinsulinaemic glucose clamp procedure in patients with severe COPD and chronic hypoxaemia, Clin Physiol Funct Imaging, 26, 271, 10.1111/j.1475-097X.2006.00686.x Wood-Baker, 2007, Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews, Respir Med, 101, 371, 10.1016/j.rmed.2006.07.013 Canis, 2007, Effects of inhaled budesonide on insulin sensitivity in nondiabetic patients with asthma and chronic obstructive pulmonary disease, Adv Ther, 24, 560, 10.1007/BF02848778 Faul, 2009, The effect of an inhaled corticosteroid on glucose control in type 2 diabetes, Clin Med Res, 7, 14, 10.3121/cmr.2009.824 Pauwels, 1999, Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European respiratory society study on chronic obstructive pulmonary disease, N Engl J Med, 340, 1948, 10.1056/NEJM199906243402503 Chakrabarti, 2009, Hyperglycaemia as a predictor of outcome during non invasive ventilation in decompensated COPD, Thorax, 10.1136/thx.2008.106989 Moretti, 2000, Incidence and causes of non-invasive mechanical ventilation failure after initial success, Thorax, 55, 819, 10.1136/thorax.55.10.819 Wouters, 2007, Systemic inflammation in chronic obstructive pulmonary disease. The role of exacerbations, Proc Am Thorac Soc, 4, 626, 10.1513/pats.200706-071TH Adrogue, 1988, Acidosis-induced glucose intolerance is not prevented by adrenergic blockade, Am J Physiol, 255, E812 Garcia-Aymerich, 2004, Physical activity and its determinants in severe chronic obstructive pulmonary disease, Med Sci Sports Exerc, 36, 1667, 10.1249/01.MSS.0000142378.98039.58 Crisafulli, 2008, Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation, Thorax, 63, 487, 10.1136/thx.2007.086371 Loukides, 1996, The effect of diabetes mellitus on the outcome of patients with chronic obstructive pulmonary disease exacerbated due to respiratory infections, Respiration, 63, 170, 10.1159/000196539 Makarevich, 2007, Evaluation of pulmonary hypertension in COPD patients with diabetes, Adv Med Sci., 52, 265 Gudmundsson, 2006, Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity, Respir Res, 7, 109, 10.1186/1465-9921-7-109 Weynand, 1999, Diabetes mellitus induces a thickening of the pulmonary basal lamina, Respiration, 66, 12, 10.1159/000029331 Strojeck, 1992, Pulmonary complications of type I (insulin-dependent) diabetic patients, Diabetologia, 35, 1173, 10.1007/BF00401373 Mori, 1992, Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus, Intern Med, 31, 189, 10.2169/internalmedicine.31.189 Hak, 2006, Incidence of GP-diagnosed respiratory tract infections according to age, gender and high-risk co-morbidity: the second Dutch national survey of general practice, Fam Pract, 23, 291, 10.1093/fampra/cmi121 Kornum, 2008, Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study, Diabetes Care, 31, 1541, 10.2337/dc08-0138 Bouter, 1991, Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976–1979 in The Netherlands, Diabetes Res Clin Pract, 12, 61, 10.1016/0168-8227(91)90131-V Baker, 2006, Hyperglycaemia and Pulmonary Infection, Proc Nutr Soc, 65, 227, 10.1079/PNS2006499 Esposito, 2002, Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress, Circulation, 106, 2067, 10.1161/01.CIR.0000034509.14906.AE Martinez-Llorens, 2004, Global muscle dysfunction and exacerbation of COPD: a cohort study, Med Clin (Barc), 122, 521 Vanhorebeek, 2005, Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients, Lancet, 365, 53, 10.1016/S0140-6736(04)17665-4 American Diabetes Association, 2009, Standards of medical care in diabetes-2009, Diabetes Care, 32, S13, 10.2337/dc09-S013 Anthonisen, 1994, Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The lung health study, JAMA, 272, 1497, 10.1001/jama.1994.03520190043033 Anthonisen, 2005, The effects of a smoking cessation intervention on 14.5-year mortality: a randomised clincial trial, Ann Intern Med, 142, 233, 10.7326/0003-4819-142-4-200502150-00005 Tonstad, 2009, Cigarette smoking, smoking cessation, and diabetes, Diab Res Clin Pract, 10, 1016 Will, 2001, Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study, Int J Epidemiol, 30, 540, 10.1093/ije/30.3.540 NICE guidance on Type 2 diabetes Rachmani, 2002, Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications, Eur J Intern Med, 13, 428, 10.1016/S0953-6205(02)00131-0 Vermeeren, 2001, Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease, Am J Clin Nutr, 73, 295, 10.1093/ajcn/73.2.295 Isoda, 2006, Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells, Arterioscler Thromb Biol, 26, 611, 10.1161/01.ATV.0000201938.78044.75 Ceriello, 2008, Thiazolidinediones as anti-inflammatory and anti-atherogenic agents, Diabetes Metab Res Rev, 24, 14, 10.1002/dmrr.790 Dandona, 2005, Insulin infusion in acute illness, J Clin Invest, 15, 2069, 10.1172/JCI26045 Vermeeren, 2004, Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial, Clin Nutr, 23, 1184, 10.1016/j.clnu.2004.03.008 Van den Berghe, 2001, Intensive insulin therapy in the critically ill patients, N Engl J Med, 345, 1359, 10.1056/NEJMoa011300 Van den Berghe, 2006, Intensive insulin therapy in the medical ICU, N Engl J Med, 354, 449, 10.1056/NEJMoa052521 Finfer, 2009, Intensive versus conventional glucose control in critically ill patients, N Engl J Med, 360, 1283, 10.1056/NEJMoa0810625 Griesdale, 2009, Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data, CMAJ, 180, 821, 10.1503/cmaj.090206 Hansen, 2003, Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels, J Clin Endocrinol Metab, 88, 1082, 10.1210/jc.2002-021478 Hemmila, 2008, Intensive insulin therapy is associated with reduced infectious complications in burn patients, Surgery, 144, 629, 10.1016/j.surg.2008.07.001 Ellger, 2008, Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity, Endocrinology, 149, 3148, 10.1210/en.2007-1558 Bellomo, 2009, What is a NICE-SUGAR for patients in the intensive care unit?, Mayo Clin Proc, 84, 400, 10.1016/S0025-6196(11)60557-0 Despres, 2006, Abdominal obesity and metabolic syndrome, Nature, 444, 881, 10.1038/nature05488 Marquis, 2005, The metabolic syndrome in patients with chronic obstructive pulmonary disease, J Cardiopulm Rehabil., 25, 226, 10.1097/00008483-200507000-00010 Watz H, Waschki B, Kirsten A, Müller KC, Kretschmar G, Meyer T et-al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009 Jun [Epub ahead of print]. Franssen, 2008, Obesity and the lung: 5. Obesity and COPD, Thorax, 63, 1110, 10.1136/thx.2007.086827 Scols, 1993, Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation, Am Rev Respir Dis, 147, 1151, 10.1164/ajrccm/147.5.1151 Martyn, 2008, Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms, Anesthesiology, 109, 137, 10.1097/ALN.0b013e3181799d45 Poulain, 2006, The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies, CMAJ, 174, 1293, 10.1503/cmaj.051299 Williams, 2003, Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes, Diabetes, 52, 1619, 10.2337/diabetes.52.7.1619 de Lucas-Ramos, 2008, Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study, Arch Bronconeumol, 44, 233, 10.1157/13119937 Janda, 2009, Statins in COPD: a systematic review, Chest, 10.1378/chest.09-0194 Mortensen, 2009, Impact of statins and ACE inhibitors on mortality after COPD exacerbations, Respir Res, 10, 45, 10.1186/1465-9921-10-45 Mancini, 2006, Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease, J Am Coll Cardiol, 47, 2554, 10.1016/j.jacc.2006.04.039 Makhsida, 2005, Hypogonadism and metabolic syndrome: implications for testosterone therapy, J Urol, 174, 827, 10.1097/01.ju.0000169490.78443.59 Basaria, 2007, Testosterone making an entry into the cardiometabolic world, Circulation, 116, 2658, 10.1161/CIRCULATIONAHA.107.740365 Van Vliet, 2005, Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 172, 1105, 10.1164/rccm.200501-114OC Isidori, 2005, Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis, Clin Endocrinol., 63, 280, 10.1111/j.1365-2265.2005.02339.x Svartberg, 2004, Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial, Respir Med, 98, 906, 10.1016/j.rmed.2004.02.015 Casaburi, 2004, Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 170, 870, 10.1164/rccm.200305-617OC